Literature DB >> 25006132

Genetic polymorphisms of vein wall remodeling in chronic venous disease: a narrative and systematic review.

Vighnesh Bharath1, Susan R Kahn2, Alejandro Lazo-Langner3.   

Abstract

Chronic venous disease encompasses a spectrum of disorders caused by an abnormal venous system. They include chronic venous insufficiency, varicose veins, lipodermatosclerosis, postthrombotic syndrome, and venous ulceration. Some evidence suggests a genetic predisposition to chronic venous disease from gene polymorphisms associated mainly with vein wall remodeling. The literature exploring these polymorphisms has not been reviewed and compiled thus far. In this narrative and systematic review, we present the current evidence available on the role of polymorphisms in genes involved in vein wall remodeling and other pathways as contributors to chronic venous disease. We searched the EMBASE, Medline, and PubMed databases from inception to 2013 for basic science or clinical studies relating to genetic associations in chronic venous disease and obtained 38 relevant studies for this review. Important candidate genes/proteins include the matrix metalloproteinases (extracellular matrix degradation), vascular endothelial growth factors (angiogenesis and vessel wall integrity), FOXC2 (vascular development), hemochromatosis (involved in venous ulceration and iron absorption), and various types of collagen (contributors to vein wall strength). The data on associations between these genes/proteins and the postthrombotic syndrome are limited and additional studies are required. These associations might have future prognostic and therapeutic implications.
© 2014 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25006132     DOI: 10.1182/blood-2014-03-558478

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  [Chronic venous insufficiency: Update on pathophysiology, diagnosis and treatment].

Authors:  P Gkogkolou; V Meyer; T Goerge
Journal:  Hautarzt       Date:  2015-05       Impact factor: 0.751

Review 2.  The post-thrombotic syndrome.

Authors:  Susan R Kahn
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

3.  Biological findings from the PheWAS catalog: focus on connective tissue-related disorders (pelvic floor dysfunction, abdominal hernia, varicose veins and hemorrhoids).

Authors:  Lyubov E Salnikova; Maryam B Khadzhieva; Dmitry S Kolobkov
Journal:  Hum Genet       Date:  2016-04-28       Impact factor: 4.132

Review 4.  Guidance for the prevention and treatment of the post-thrombotic syndrome.

Authors:  Susan R Kahn; Jean-Philippe Galanaud; Suresh Vedantham; Jeffrey S Ginsberg
Journal:  J Thromb Thrombolysis       Date:  2016-01       Impact factor: 2.300

5.  Genome-wide association analysis for chronic venous disease identifies EFEMP1 and KCNH8 as susceptibility loci.

Authors:  Eva Ellinghaus; David Ellinghaus; Petra Krusche; Aljoscha Greiner; Claudia Schreiber; Susanna Nikolaus; Christian Gieger; Konstantin Strauch; Wolfgang Lieb; Philip Rosenstiel; Norbert Frings; Andreas Fiebig; Stefan Schreiber; Andre Franke
Journal:  Sci Rep       Date:  2017-04-04       Impact factor: 4.379

6.  Behavior of Smooth Muscle Cells under Hypoxic Conditions: Possible Implications on the Varicose Vein Endothelium.

Authors:  Miguel A Ortega; Beatriz Romero; Ángel Asúnsolo; Felipe Sainz; Clara Martinez-Vivero; Melchor Álvarez-Mon; Julia Buján; Natalio García-Honduvilla
Journal:  Biomed Res Int       Date:  2018-10-18       Impact factor: 3.411

7.  Extracellular matrix remodelling in response to venous hypertension: proteomics of human varicose veins.

Authors:  Javier Barallobre-Barreiro; Rahmi Oklu; Marc Lynch; Marika Fava; Ferheen Baig; Xiaoke Yin; Temo Barwari; David N Potier; Hassan Albadawi; Marjan Jahangiri; Karen E Porter; Michael T Watkins; Sanjay Misra; Julianne Stoughton; Manuel Mayr
Journal:  Cardiovasc Res       Date:  2016-04-11       Impact factor: 10.787

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.